| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 10 |
| 1 | TACROLIMUS | 10 |
| 2 | METHOTREXATE | 9 |
| 3 | METHOTREXATE SODIUM | 9 |
| 4 | MYCOPHENOLATE MOFETIL | 8 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 8 |
| 6 | PREDNISONE | 8 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 8 |
| 8 | TACROLIMUS OINTMENT 0.1% | 8 |
| 9 | FINGOLIMOD | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DANTROLENE SODIUM | 4 | 0.0035 |
| 1 | FLUCYTOSINE | 3 | 0.0021 |
| 2 | FINGOLIMOD HYDROCHLORIDE | 6 | 0.0012 |
| 3 | IDELALISIB | 3 | 0.0004 |
| 4 | RALTEGRAVIR | 2 | 0.0004 |
| 5 | EFAVIRENZ | 4 | 0.0004 |
| 6 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| 7 | GEMTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 8 | ENTECAVIR | 3 | 0.0003 |
| 9 | ANAKINRA | 4 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 3 | 0.0021 |
| 1 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 6 | 0.0004 |
| 2 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 4 | 0.0002 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 8 | Sympathomimetic-like Agent [EPC] | 4 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |